CrystalO Biopharma

Shenzhen, China · Founded 2019 · Privately Held (backing)

Manufacturer of membrane protein drugs intended for neuropsychiatric disorders, chronic kidney disease and cardiovascular disease. CrystalO Biopharma is based in Shenzhen, China and was founded in 2019. It has raised $17.1 million.

Last price · $/share
—
Implied valuation
—
Total raised
$17.1M
Last round
—

Who backs CrystalO Biopharma?

9 investors
InvestorType
Guangdong Technology Financial GroupOther
Goldport CapitalOther
Fuho CapitalVenture capital
HitGen—
Longmen Capital—
Shenzhen Qianhai Hongzhao Fund Management—
Sp@ce Holding Group—
Tiantu Capital—
Triwise Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

CrystalO Biopharma investors

9 investors are on record for CrystalO Biopharma, including Guangdong Technology Financial Group, Goldport Capital, Fuho Capital and HitGen.

Free account
More of CrystalO Biopharma with a free account
  • ·Watch CrystalO Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like CrystalO Biopharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View